{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "EMT process",
      "N-cadherin",
      "major signaling pathways",
      "thyroid cancer"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "28042956",
  "DateCompleted": {
    "Year": "2018",
    "Month": "03",
    "Day": "02"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "02",
    "Day": "08"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.18632/oncotarget.14101"
    ],
    "Journal": {
      "ISSN": "1949-2553",
      "JournalIssue": {
        "Volume": "8",
        "Issue": "5",
        "PubDate": {
          "Year": "2017",
          "Month": "Jan",
          "Day": "31"
        }
      },
      "Title": "Oncotarget",
      "ISOAbbreviation": "Oncotarget"
    },
    "ArticleTitle": "N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.",
    "Pagination": {
      "StartPage": "8131",
      "EndPage": "8142",
      "MedlinePgn": "8131-8142"
    },
    "Abstract": {
      "AbstractText": [
        "Epithelial-mesenchymal transition (EMT), a crucial step in disease progression, plays a key role in tumor metastasis. N-cadherin, a well-known EMT marker, acts as a major oncogene in diverse cancers, whereas its functions in thyroid cancer remains largely unclear. This study was designed to explore the biological roles and related molecular mechanism of N-cadherin in thyroid tumorigenesis. Quantitative RT-PCR (qRT-PCR) and immunohistochemistry assays were used to evaluate N-cadherin expression. A series of in vitro studies such as cell proliferation, colony formation, cell cycle, apoptosis, migration and invasion assays were performed to determine the effect of N-cadherin on malignant behavior of thyroid cancer cells. Our results showed that N-cadherin was significantly upregulated in papillary thyroid cancers (PTCs) as compared with non-cancerous thyroid tissues. N-cadherin knockdown markedly inhibited cell proliferation, colony formation, cell migration and invasion, and induced cell cycle arrest and apoptosis. On the other hand, ectopic expression of N-cadherin promoted thyroid cancer cell growth and invasiveness. Mechanically, our data demonstrated that tumor-promoting role of N-cadherin in thyroid cancer was closely related to the activities of the MAPK/Erk, the phosphatidylinositol-3-kinase (PI3K)/Akt and p16/Rb signaling pathways in addition to affecting the EMT process. Altogether, our findings suggest that N-cadherin promotes thyroid tumorigenesis by modulating the activities of major signaling pathways and EMT process, and may represent a potential therapeutic target for this cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, Shanxi Provincial Crops Hospital of Chinese People's Armed Police Force, Xi'an 710054, P.R. China."
          }
        ],
        "LastName": "Da",
        "ForeName": "Chenxing",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Wu",
        "ForeName": "Kexia",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, Shanxi Provincial Crops Hospital of Chinese People's Armed Police Force, Xi'an 710054, P.R. China."
          }
        ],
        "LastName": "Yue",
        "ForeName": "Chenli",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Bai",
        "ForeName": "Peisong",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Rong",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Wang",
        "ForeName": "Guanjie",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Zhao",
        "ForeName": "Man",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Lv",
        "ForeName": "Yanyan",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Endocrinology, Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, P.R. China."
          }
        ],
        "LastName": "Hou",
        "ForeName": "Peng",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Oncotarget",
    "NlmUniqueID": "101532965",
    "ISSNLinking": "1949-2553"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, CD"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CDH2 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CDKN2A protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cadherins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cyclin-Dependent Kinase Inhibitor p16"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Retinoblastoma Protein"
    },
    {
      "RegistryNumber": "EC 2.7.1.137",
      "NameOfSubstance": "Phosphatidylinositol 3-Kinase"
    },
    {
      "RegistryNumber": "EC 2.7.11.1",
      "NameOfSubstance": "Proto-Oncogene Proteins c-akt"
    },
    {
      "RegistryNumber": "EC 2.7.11.24",
      "NameOfSubstance": "Extracellular Signal-Regulated MAP Kinases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Antigens, CD"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Apoptosis"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Cadherins"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Carcinoma, Papillary"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Cycle"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Movement"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Proliferation"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cyclin-Dependent Kinase Inhibitor p16"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Epithelial-Mesenchymal Transition"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Extracellular Signal-Regulated MAP Kinases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression Regulation, Neoplastic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Neoplasm Invasiveness"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Phosphatidylinositol 3-Kinase"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Proto-Oncogene Proteins c-akt"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA Interference"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Retinoblastoma Protein"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Signal Transduction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Thyroid Cancer, Papillary"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Thyroid Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Transfection"
    }
  ],
  "CoiStatement": "<b>CONFLICTS OF INTEREST</b>. The authors declare no conflicts of interest."
}